Replies to post #213769 on Biotech Values

[DewDiligence]

ASND selling $143.8M* of ADSs on unspecified terms:

https://globenewswire.com/news-release/2017/09/26/1133034/0/en/Ascendis-Pharma-A-S-Announces-Proposed-Public-Offering-of-ADSs.html

*Assuming exercise of underwriter’s option.